RALA |
RAP2B |
||
---|---|---|---|
Gene Name | v-ral simian leukemia viral oncogene homolog A (ras related) | RAP2B, member of RAS oncogene family | |
Image | No pdb structure | ||
Gene Ontology Annotations | Cellular Component | ||
Molecular Function | |||
Biological Process | |||
Pathways | |||
Drugs | |||
Diseases | |||
GWAS | |||
Protein-Protein Interactions | 32 interactors: ARF1 CALM1 CNKSR2 EXOC1 EXOC2 EXOC3 EXOC4 EXOC5 EXOC6B EXOC7 EXOC8 FLNA HRAS LRPAP1 LSM2 PIH1D2 PLCD1 PLD1 PPP2R1B RAB34 RAB8B RALBP1 RALGPS1 RAP1A RAP2A RAP2B RASSF5 REPS1 RGL2 RGL4 SMAD4 YBX3 | 8 interactors: CAMK2B PDE6D RALA RALGDS RAPGEF2 RAPGEF5 RASSF5 RUNDC3A | |
Entrez ID | 5898 | 5912 | |
HPRD ID | 01549 | 01548 | |
Ensembl ID | ENSG00000006451 | ||
Uniprot IDs | P11233 | P61225 | |
PDB IDs | 1UAD 1ZC3 1ZC4 2A78 2A9K 2BOV | ||
Enriched GO Terms of Interacting Partners? |
|
|
|
Tagcloud ? | adoptive
antitumor
capability
chimeric
combining
effectors
engineered
fused
genetically
gtp
immunotherapeutic
killer
meaningful
mhc
moieties
ncr1
ncrs
nk
nkp46
partly
proto
ralb
recognition
recognize
regressions
remarkable
retrovirally
termed
|
activates
anchorage
arrest
balance
binds
counters
damage
decision
depends
evokes
fate
genomic
integrative
interference
mediate
oncogene
overexpressed
p53
player
possibility
pro
programs
raise
reveals
sensitize
sensitizes
ultimate
upon
weak
|
|
Tagcloud (Difference) ? | adoptive
antitumor
capability
chimeric
combining
effectors
engineered
fused
genetically
gtp
immunotherapeutic
killer
meaningful
mhc
moieties
ncr1
ncrs
nk
nkp46
partly
proto
ralb
recognition
recognize
regressions
remarkable
retrovirally
termed
|
activates
anchorage
arrest
balance
binds
counters
damage
decision
depends
evokes
fate
genomic
integrative
interference
mediate
oncogene
overexpressed
p53
player
possibility
pro
programs
raise
reveals
sensitize
sensitizes
ultimate
upon
weak
|
|
Tagcloud (Intersection) ? |